Industrial Biotechnology Technology Offers

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Synthesis of bioactive compounds We offer developed methods for the synthesis of known active substances by reaction in the presence of ultrasound and other eco-friendly methods. We also offer synthesis on request or a ready library of bioactive compounds with anti-cancer effect.

Synthesis of bioactive compounds

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Bioactive haemostatic agents with advanced biological properties The technology comprises the obtainment of physically crosslinked aerogel with a unique chemical structure, which is responsible for the exceptional sorption capacity and antioxidant properties leading to scavenging of reactive radicals, especially oxygen (ROSS). Biomaterials are obtained from resources of fungal and plant origin. The use of biocompatible substances eliminates the use of toxic reagents, so the method of preparation is in line with the limitations of Green Chemistry.

Alex Michine posted this:
CEO at MetGen

METNIN™ TECHNOLOGY IS A LIGNIN REFINERY - SUSTAINABLE PATH TO REPLACE OLD BASED CHEMISTRY IN HIGH VALUE END USER PRODUCTS METNIN™ Technology is developed to refine lignin to end-user specific characteristics. Our technology is agnostic to lignin source and provides the missing link in the value-chain between crude lignin and high value lignin fractions for specific end user products. Metnin™ is enabling lignin valorisation towards wide range of drop-in sustainable solutions in e.g. coatings, resins, plasticizers, polyurethanes, and moisture/humidity resistance packaging. MetGen’s technology has been proven in multiple pre-commercial installations and enables cost-efficient conversion of lignin into cascade of intermediate building blocks of specific molecular size.Basic engineering package, CAPEX and OPEX estimate available.

METNIN™ TECHNOLOGY IS A LIGNIN REFINERY - SUSTAINABLE PATH TO REPLACE OLD BASED CHEMISTRY IN HIGH VALUE END USER PRODUCTS

Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante

Novel bioadhesive for wound closure in animals or humans The Adhesion and Adhesives Laboratory research group has developed a new biomaterial for use as adhesive or tissue sealant applicable to both animals and humans. This invention solves the disadvantages of the adhesives known so far presenting optimal properties such as biocompatibility with living tissues, high adhesive capacity, adaptable to the tissue of the wound being bond, absence of toxicity and tissue regeneration properties. The group is looking for companies interested in acquiring this technology for commercial exploitation.

Novel bioadhesive for wound closure in animals or humans

Universitat Politècnica de Catalunya - UPC posted this:

Enzymatic aqueous preparation for the surface functionalization of paper or cellulosic substrates A new biotechnological product for the chemical modification of the surface of cellulosic substrates has been patented. The bioproduct is obtained from an enzyme-mediator system, and several properties can be easily conferred to substrates applying very low concentrations of this enzymatic product in their surface. Partners to further develop the product and/or to establish commercial agreements along with technical cooperation are sought.

Enzymatic aqueous preparation for the surface functionalization of paper or cellulosic substrates

Biótica, Bioquímica Analítica,S.L. posted this:

ULISENS Legionella Desktop Analyzer Fully automated equipment for 1 hour-determination of Legionella in concentrated water samples. The #ULISENS Desktop is a portable computer that makes it possible to analyze #Legionella in filtered water samples. With the "nespresso" philosophy, it uses a recyclable cartridge. "Push & Run" and the data is available in only 1 hour. It automates the rapid immunomagnetic method listed in the norm UNE100030:2017 for the control and prevention of #Legionella. (https://youtu.be/baiHP26xwCs)

ULISENS Legionella Desktop Analyzer

Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante

Antibacterial alternative to antibiotics, with high specificity against Escherichia coli The "Molecular Microbiology" research group at the University of Alicante has modified several phage proteins (Poll-N and UK-C) that have high specificity against Escherichia coli (E. coli), but not against other Gram-negative (G-) bacteria. For these reasons, their use as a specific antimicrobial against E. coli is potentially interesting, especially in the case of contaminated food, cosmetics or water. It would also be useful in the treatment of diseases (infections) caused by E. coli. The presence of a histidine tail attached to the phage proteins not only facilitates their purification but also improves lysis efficiency without the need of cell permeabilization treatments. Companies interested in the commercial exploitation of the technology through license agreements and/or technical cooperation are sought.

Antibacterial alternative to antibiotics, with high specificity against Escherichia coli

University of Vigo posted this:

Valorization of whey and vinasses by producing antimicrobial extracts using biotechnological processes This invention is based on the production of antimicrobial extracts with potential application against pathogenic microorganisms. The biotechnological production of antimicrobial metabolites was carried out using Lactobacillus plantarum strains. Two industrial wastes, whey, and wine distilled lees (or vinasses) were assayed in order to make the process economically competitive with regard to the chemical one. The extracts are mainly composed by lactic acid, 3-phenyllactic and bacteriocins. Whey was enzymatically hydrolyzed and the solutions were fermented sequentially or simultaneously. The bioprocesses were carried out continuously or discontinuously

jaume mir posted this:
CEO at Biochemize SL

Production of D-panose through an innovative microbial fermentation process D-panose (α-D-Glucopyranosyl-(1->6)-α-D-glucopyranosyl-(1->4)-D-glucose) is a high value tri-saccharide molecule that has been proposed as a low caloric content sugar (i), as a promoter for probiotics (ii) and having outstanding anti-oxidant. anti-tumoral properties (iii). Currently this rare sugar is obtained by chemical synthesis, and this is the reason for its extremely high cost/ price (1) and poor industrial uses (2). At Biochemize SL we have developed a (very simple) production process that leads the production of high pure (more than 99%) D-panose, through a microbial fermentation process using a recombinant bacteria strain engineered by us, at a significantly lower operational/production cost. We offer this process to be operated by/ be licensed to a manufacturing company operating in this area.

Production of D-panose through an innovative microbial fermentation process

Consejo Superior de Investigaciones Científicas posted this:

Gold catalysts supported on mixed oxides highly efficient and stable in the Water Gas Shift reaction CSIC, in collaboration with the University of Seville, has developed the synthesis of gold catalysts highly efficient in the Water Gas Shift Reaction (WGS). The catalysts, based on gold supported on CuO/ZnO/Al2O3 mixed oxides with hydrotalcite structure, are able to work without any pre-treatment and are robust against changes in the reaction operation conditions, that make them very useful for production and/or H2 purification processes for fuel processors coupled to fuel cells. An offer for Patent Licensing

Gold catalysts supported on mixed oxides highly efficient and stable in the Water Gas Shift reaction

Consejo Superior de Investigaciones Científicas posted this:

Overcoming resistance to Beta-lactam antibiotics in Bacterial species CSIC and the University of Würzburg have developed a new method to eliminate antibiotic-resistant bacterial infections using classical antibiotics previously discarded due the occurrence of antibiotic resistance. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing

Overcoming resistance to Beta-lactam antibiotics in Bacterial species

Consejo Superior de Investigaciones Científicas posted this:

Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.CSIC has developed a procedure for the biotechnological production of 11α hydroxylated steroids by generating and subsequent use of recombinant bacteria. These recombinant bacteria allow to perform microbial biotransformation processes that result in 11αhydroxylated steroid compounds from raw materials such as phytosterols and intermediate products efficiently and economically. These compounds have numerous applications in pharmacology. Companies are sought for implementing and commercializing the new technology under patent license agreement. An offer for Patent Licensing

Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.

Consejo Superior de Investigaciones Científicas posted this:

Enzymatic production of 2,5-furandicarboxylic acid from 5-methoxymethylfurfura a a l l CSIC, University of Zaragoza and Technische Universität Dresden have developed an enzymatic composition and its use as an enzymatic cascade for the production of 2,5-furandicarboxylic acid (FDCA) from 5-methoxymethylfurfural (MMF). This cascade is self-sustained with the only consumption of atmospheric oxygen and the MMF itself. The method can be applied to the conversion of MMF into FDCA step in the bioplastic producing industry, switching from the current inorganic catalysts employed to the use of enzymes for the FDCA production. Industrial partners are being sought to develop and commercialize the enzymatic composition through a patent licence agreement. An offer for Patent Licensing

Enzymatic production of 2,5-furandicarboxylic acid from 5-methoxymethylfurfura

Consejo Superior de Investigaciones Científicas posted this:

Regulatory compounds of synaptic transmission for the treatment of neurological diseases The CSIC and IRYCIS (Ramón y Cajal Institute for Health Research) have developed a group of compounds. These compounds have the ability to regulate the number of synapses that are formed between neurons, as well as the probability that neurotransmitters are released from these, because they have the capability of modulate the interactions that take place between the regulatory proteins NCS-1 and Ric8a that regulate these two independent processes. Due to these neuromodulatory properties, these compounds are useful for the treatment of neurological diseases as Alzheimer's disease, Huntington or Parkinson's diseases among others. Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent license agreement. An offer for Patent Licensing

Regulatory compounds of synaptic transmission for the treatment of neurological diseases

Irene Uceda posted this:
Employee at Consejo Superior de Investigaciones Científicas

An electrical stable electrochemical sensor device based on Electrolyte-gated field-effect transistor (EGFET)CSIC has developed an electrolyte-gated field-effect transistor (EGFET) with enhanced electrical stability. These new EGFETs operate in aqueous environment, and are stable for more than 12 hours under continuous operation, greatly surpassing current state-of-the-art EGFETs. The increased stability makes them suitable for real life applications. Industrial partners are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing

An electrical stable electrochemical sensor device based on Electrolyte-gated field-effect transistor (EGFET)

1
2
3
4
5